Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H12N4O4S |
Molecular Weight | 284.292 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C2N=CNC3=S
InChI
InChIKey=NKGPJODWTZCHGF-KQYNXXCUSA-N
InChI=1S/C10H12N4O4S/c15-1-4-6(16)7(17)10(18-4)14-3-13-5-8(14)11-2-12-9(5)19/h2-4,6-7,10,15-17H,1H2,(H,11,12,19)/t4-,6-,7-,10-/m1/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/3412035Curator's Comment: Description was created based on several sources, including
https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=39497
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3412035
Curator's Comment: Description was created based on several sources, including
https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=39497
THIOINOSINE (Methylmercaptopurine riboside, NSC- 40774) is a purine derivative with antineoplastic and anti-angiogenic properties. THIOINOSINE is readily converted in cells to its active form, 6-methylmercaptopurine ribonucleoside 5'- monophosphate (MMPR-P), by the enzyme adenosine kinase. THIOINOSINE inhibits amidophosphoribosyltransferase, the first committed step in de novo purine synthesis, and inhibits fibroblast growth factor-2 (FGF2)-induced cell proliferation. It has been used similarly to Mercaptopurine in the treatment of Leukemia. It has being tested in clinical trials for advanced pancreatic cancer.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Bacillus anthracis spore germination Sources: https://www.ncbi.nlm.nih.gov/pubmed/20921305 |
40.0 µM [IC50] | ||
Target ID: Murine leukemia cells growth Sources: https://www.ncbi.nlm.nih.gov/pubmed/1906107 |
68.0 nM [IC50] | ||
Target ID: Free radical scavenging Sources: https://www.ncbi.nlm.nih.gov/pubmed/19692149 |
3.9 µM [IC50] | ||
Target ID: Murine lymphoma cells growth Sources: https://www.ncbi.nlm.nih.gov/pubmed/221658 |
250.0 nM [EC50] | ||
Target ID: Q63433 Gene ID: 29355.0 Gene Symbol: Pkn1 Target Organism: Rattus norvegicus (Rat) Sources: https://www.ncbi.nlm.nih.gov/pubmed/1309569 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Purine analogs as potential anticytomegalovirus agents. | 1969 Sep |
|
Synthesis and antiviral activity of certain carbamoylpyrrolopyrimidine and pyrazolopyrimidine nucleosides. | 1982 Nov |
|
Captopril and 6-mercaptopurine: whose SH possesses higher antioxidant ability? | 2009 Dec |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1060503
300 mg/m2/day by rapid i.v. injection
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1309569
THIOINOSINE blocked PKN with apparent Ki values between 100 and 500uM in PC12 pheochromocytoma cells.
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C574
Created by
admin on Fri Dec 15 16:16:36 GMT 2023 , Edited by admin on Fri Dec 15 16:16:36 GMT 2023
|
||
|
NCI_THESAURUS |
C1556
Created by
admin on Fri Dec 15 16:16:36 GMT 2023 , Edited by admin on Fri Dec 15 16:16:36 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
D013868
Created by
admin on Fri Dec 15 16:16:36 GMT 2023 , Edited by admin on Fri Dec 15 16:16:36 GMT 2023
|
PRIMARY | |||
|
DTXSID5046019
Created by
admin on Fri Dec 15 16:16:36 GMT 2023 , Edited by admin on Fri Dec 15 16:16:36 GMT 2023
|
PRIMARY | |||
|
209-371-5
Created by
admin on Fri Dec 15 16:16:36 GMT 2023 , Edited by admin on Fri Dec 15 16:16:36 GMT 2023
|
PRIMARY | |||
|
46S541971T
Created by
admin on Fri Dec 15 16:16:36 GMT 2023 , Edited by admin on Fri Dec 15 16:16:36 GMT 2023
|
PRIMARY | |||
|
4988-64-1
Created by
admin on Fri Dec 15 16:16:36 GMT 2023 , Edited by admin on Fri Dec 15 16:16:36 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
100000127651
Created by
admin on Fri Dec 15 16:16:36 GMT 2023 , Edited by admin on Fri Dec 15 16:16:36 GMT 2023
|
PRIMARY | |||
|
676166
Created by
admin on Fri Dec 15 16:16:36 GMT 2023 , Edited by admin on Fri Dec 15 16:16:36 GMT 2023
|
PRIMARY | |||
|
C877
Created by
admin on Fri Dec 15 16:16:36 GMT 2023 , Edited by admin on Fri Dec 15 16:16:36 GMT 2023
|
PRIMARY | |||
|
574-25-4
Created by
admin on Fri Dec 15 16:16:36 GMT 2023 , Edited by admin on Fri Dec 15 16:16:36 GMT 2023
|
PRIMARY | |||
|
4911
Created by
admin on Fri Dec 15 16:16:36 GMT 2023 , Edited by admin on Fri Dec 15 16:16:36 GMT 2023
|
PRIMARY | |||
|
CHEMBL448290
Created by
admin on Fri Dec 15 16:16:36 GMT 2023 , Edited by admin on Fri Dec 15 16:16:36 GMT 2023
|
PRIMARY | |||
|
SUB33710
Created by
admin on Fri Dec 15 16:16:36 GMT 2023 , Edited by admin on Fri Dec 15 16:16:36 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD